Hilde B.
- Country
- Belgium
- Department
- Anima
Research Overview
- Efficacy and Safety of Eloralintide in Adults with Obesity or Overweight without Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 2a Randomized, Double‑Blind, Placebo‑Controlled Study of LY4005130 in Adults with Non‑Segmental Vitiligo
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Dupilumab in Adults with Moderate‑to‑Severe Lichen Simplex Chronicus (Neurodermatitis)
Data & Insights
Has run more than one trial at 15 of 137 partner sites.
Specializations
Respiratory Medicine
Specializes in the investigation of novel therapeutic approaches for chronic rhinosinusitis with nasal polyps, with particular attention to treatments targeting nasal congestion and polyp reduction. The investigator explores innovative monoclonal antibody treatments in this field.
- Nasal Polyp Management
- Chronic Rhinosinusitis
- Anti-IL-33 Therapy
Infectious Disease
Focuses on preventive strategies against COVID-19, particularly investigating novel antibody-based prophylactic treatments. The investigator examines innovative approaches to protect against various SARS-CoV-2 variants.
- COVID-19 Prevention
- Antibody Therapeutics
- Viral Variant Protection
Dermatology
Concentrates on therapeutic solutions for Lichen Simplex Chronicus and related dermatological conditions. The investigator studies advanced treatments for moderate-to-severe cases that have not responded adequately to conventional topical therapies.
- Chronic Pruritus Management
- Neurodermatitis Treatment
- Immunomodulatory Therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.